SLITRK3 and neoplasm: Furthermore, SLITRK3 amplification recurring in LUSC at a frequency of 30% with the mechanistic role we have uncovered can explain why a previous tumor immunostaining study reported NTRK3 protein is absent in LUAD samples but detected in approximately 30% of LUSC samples [33].